Publication: 2893

Publication: 2893

A phase 3 study of androgen annihilation in high-risk biochemically relapsed prostate cancer: an Alliance Foundation trial (AFT-19)

DOI

URL

URL

Google Scholar

Citation:: J Clin Oncol vol 36 (15_suppl) abstr TPS5090

Meeting Instance:: ASCO 2018
Year:: 2018
Type:: Abstract
Sub type:: Poster Discussion
Funding:: AFT
Endpoint:: No-Endpoint
Analysis:: Trial-Description-Only
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: epreprint

Note:

Methodological:: No
Biospecimen:: No
SDC:: Yes

Parents:: None
Children:: None

Program:: OGC
Primary Committee:: GU
Sec. Committees:

Pharmas:
Grants:

Corr. Author:
Authors:: Rahul Aggarwal Scott Eggener Ronald Chen Glenn Heller Akash Patnaik Han Xiao Douglas Weckstein James Mohler Mark Watson Mary-Ellen Taplin Linda Skoog-Sluman Meryl Pereji Eunice Aikins-Afful John Kellogg Parsons Charles J. Ryan Michael M. Morris

Networks:: CA249, CA824, KANSAS, LAPS-IL057, LAPS-MA036, LAPS-MO011, LAPS-NY016, LAPS-NY158, MN022, NH038

Study: AFT-19
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 3

Keywords: